India is well positioned to attract future investments, says Eli Lilly's Patrick Johnson

Faster ApprovalsFaster, predictable, and globally aligned clinical trial approvals are critical for India to attract high-value research and strengthen scientific capability and capacityPatrick JohnsonExecutive Vice President of Eli Lilly and Company and President of Lilly International

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/SmdTnVf
via IFTTT